{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:44:34Z","timestamp":1778694274283,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.arth.2025.04.066","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T02:59:06Z","timestamp":1746586746000},"page":"2586-2592.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rivaroxaban Utilization Without Perioperative Tranexamic Acid Is Associated With an Increased Risk of Bleeding Complications Following Total Joint Arthroplasty"],"prefix":"10.1016","volume":"40","author":[{"given":"Ryan C.","family":"Palmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar S.","family":"Telang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Dobitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kareem J.","family":"Kebaish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1293-1702","authenticated-orcid":false,"given":"Nathanael D.","family":"Heckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay R.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2025.04.066_bib1","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.arth.2023.02.028","article-title":"Safety and efficacy of rivaroxaban in primary total hip and knee arthroplasty","volume":"38","author":"Piple","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.066_bib2","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of cardiology\/American heart association task force on practice guidelines and the heart rhythm society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.arth.2025.04.066_bib3","first-page":"768","article-title":"Rivaroxaban (Xarelto) for prevention of thromboembolic events","volume":"86","author":"Erlich","year":"2012","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.arth.2025.04.066_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jjcc.2019.01.001","article-title":"Real-world outcomes of the Xarelto post-Authorization safety & effectiveness study in Japanese patients with atrial fibrillation (XAPASS)","volume":"74","author":"Ikeda","year":"2019","journal-title":"J Cardiol"},{"key":"10.1016\/j.arth.2025.04.066_bib5","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arth.2025.04.066_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)60880-6","article-title":"Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial","volume":"372","author":"Kakkar","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.arth.2025.04.066_bib7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arth.2025.04.066_bib8","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1056\/NEJMoa076016","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty","volume":"358","author":"Lassen","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arth.2025.04.066_bib9","author":"Aspirin"},{"key":"10.1016\/j.arth.2025.04.066_bib11","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2106\/JBJS.L.01335","article-title":"Predictors of perioperative blood loss in total joint arthroplasty","volume":"95","author":"Park","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.04.066_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1537-2995.2003.00348.x","article-title":"Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe","volume":"43","author":"Rosencher","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.arth.2025.04.066_bib13","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.arth.2018.08.002","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.066_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.arth.2022.08.026","article-title":"Tranexamic acid and prothrombotic complications following total hip and total knee arthroplasty: a population-wide safety analysis accounting for surgeon selection bias","volume":"38","author":"Heckmann","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.066_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2106\/JBJS.23.00254","article-title":"Tranexamic acid is safe in patients with a history of venous thromboembolism undergoing total joint arthroplasty","volume":"106","author":"Richardson","year":"2024","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.04.066_bib16","series-title":"Premier healthcare database white paper: data that informs and performs","year":"2020"},{"key":"10.1016\/j.arth.2025.04.066_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/ALN.0000000000003772","article-title":"Safety of tranexamic acid in hip and knee arthroplasty in high-risk patients","volume":"135","author":"Poeran","year":"2021","journal-title":"Anesthesiology"},{"key":"10.1016\/j.arth.2025.04.066_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4829","article-title":"Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety","volume":"349","author":"Poeran","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.arth.2025.04.066_bib19","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1016\/j.arth.2018.06.023","article-title":"The efficacy of tranexamic acid in total hip arthroplasty: a network meta-analysis","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.066_bib20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jss.2013.03.099","article-title":"A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty","volume":"184","author":"Tan","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.arth.2025.04.066_bib21","series-title":"Tranexamic acid","author":"Chauncey","year":"2023"},{"key":"10.1016\/j.arth.2025.04.066_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40560-016-0201-0","article-title":"Tranexamic acid and trauma-induced coagulopathy","volume":"5","author":"Nishida","year":"2017","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.arth.2025.04.066_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1302\/0301-620X.101B2.BJJ-2018-0898.R1","article-title":"A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty","volume":"101-B","author":"Clav\u00e9","year":"2019","journal-title":"Bone Joint J"},{"key":"10.1016\/j.arth.2025.04.066_bib24","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/08941939.2019.1690602","article-title":"Efficacy and safety of tranexamic acid combined with rivaroxaban in primary total knee arthroplasty: a meta-analysis of randomized controlled trials","volume":"34","author":"Meng","year":"2021","journal-title":"J Invest Surg"},{"key":"10.1016\/j.arth.2025.04.066_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.45883","article-title":"Venous thromboembolism in total hip and total knee arthroplasty","volume":"6","author":"Simon","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.arth.2025.04.066_bib26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/medicina56090416","article-title":"An update on venous thromboembolism rates and prophylaxis in hip and knee arthroplasty in 2020","volume":"56","author":"Santana","year":"2020","journal-title":"Medicina"},{"key":"10.1016\/j.arth.2025.04.066_bib27","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1016\/j.arth.2023.02.066","article-title":"Aspirin for venous thromboembolic prophylaxis following total hip and total knee arthroplasty: an analysis of safety and efficacy accounting for surgeon selection bias","volume":"38","author":"Heckmann","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.066_bib28","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.2106\/JBJS.23.00146","article-title":"Increased risk of venous thromboembolism in patients with postoperative anemia after total joint arthroplasty: are transfusions to blame?","volume":"105","author":"Liu","year":"2023","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.04.066_bib29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.arth.2016.08.020","article-title":"The efficacy of combined use of rivaroxaban and tranexamic acid on blood conservation in minimally invasive total knee arthroplasty a double-blind randomized, controlled trial","volume":"32","author":"Wang","year":"2017","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.066_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11420-014-9384-x","article-title":"Blood management may have an impact on length of stay after total hip arthroplasty","volume":"10","author":"Bou Monsef","year":"2014","journal-title":"HSS J"},{"key":"10.1016\/j.arth.2025.04.066_bib31","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1213\/01.ANE.0000150610.44631.9D","article-title":"Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalization","volume":"100","author":"Weber","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.arth.2025.04.066_bib32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.arth.2015.10.013","article-title":"Comparative risk of transfusion and incremental total hospitalization cost for primary unilateral, bilateral, and revision total knee arthroplasty procedures","volume":"31","author":"Nichols","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.066_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2106\/JBJS.L.01041","article-title":"Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty","volume":"96","author":"Newman","year":"2014","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.04.066_bib34","first-page":"355","article-title":"Is homologous blood transfusion a risk factor for infection after hip replacement?","volume":"44","author":"Steinitz","year":"2001","journal-title":"Can J Surg"},{"key":"10.1016\/j.arth.2025.04.066_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1537-2995.2005.04149.x","article-title":"Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty","volume":"45","author":"Innerhofer","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.arth.2025.04.066_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00263-0","article-title":"Blood transfusions increase the risk for venous thromboembolism events following total joint arthroplasty","volume":"11","author":"Shohat","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.arth.2025.04.066_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13018-019-1270-2","article-title":"Perioperative allogenic blood transfusion increases the incidence of postoperative deep vein thrombosis in total knee and hip arthroplasty","volume":"14","author":"Jiang","year":"2019","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.arth.2025.04.066_bib38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nm0302-247","article-title":"CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism","volume":"8","author":"Andre","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.arth.2025.04.066_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11239-006-5206-4","article-title":"Proinflammatory, immunomodulating, andprothrombotic properties of anemia and red blood cell transfusions","volume":"21","author":"Twomley","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.arth.2025.04.066_bib40","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.arth.2024.11.011","article-title":"Tranexamic acid is safe in arthroplasty patients who have a history of venous thromboembolism: an analysis accounting for surgeon selection bias","volume":"40","author":"Palmer","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.066_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.artd.2024.101548","article-title":"Perioperative tranexamic acid should be considered for total joint arthroplasty patients receiving apixaban for thromboprophylaxis","volume":"30","author":"Telang","year":"2024","journal-title":"Arthroplast Today"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325004590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325004590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:05:14Z","timestamp":1758189914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540325004590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0883540325004590"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2025.04.066","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rivaroxaban Utilization Without Perioperative Tranexamic Acid Is Associated With an Increased Risk of Bleeding Complications Following Total Joint Arthroplasty","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2025.04.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}